SCHEMBL21066282

SCHEMBL21066282

O=C(CCCCC(=O)OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)COC(=O)CCCCC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)COC(=O)CCCCC(=O)OCC(O)C(O)C(O)C(O)CO)OCC(O)C(O)C(O)C(O)CO

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.51
KDM4E B2RXH2 1/20 0.51
DUSP3 P51452 1/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
MAPT P10636 1/20 0.46
PRKCA P17252 3/20 0.45
PRKCE Q02156 2/20 0.45
PRKCQ Q04759 2/20 0.45
PRKCD Q05655 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
DGKA P23743 1/20 0.44
TDP1 Q9NUW8 2/20 0.42
PDE4A P27815 1/20 0.42
ALDH1A1 P00352 1/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
ATM Q13315 1/20 0.41
USP2 O75604 1/20 0.39
SLCO1B1 Q9Y6L6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19899603 1.00 LMNA (0.51) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL20493977 1.00 LMNA (0.51) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL18668137 0.93 LMNA (0.46) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL20493979 0.93 LMNA (0.46) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL19899605 0.93 LMNA (0.46) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL10486728 0.93 LMNA (0.46) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL21523892 0.93 LMNA (0.46) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL19899604 0.93 LMNA (0.46) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL4351308 0.93 LMNA (0.50) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL7046105 0.91 LMNA (0.66) LMNAKDM4EDUSP3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190194380-A1 METHOD FOR PRODUCING POLYESTER POLYOLS AND USE THEREOF IN POLYURETHANE TEREOS STARCH & SWEETENERS BELGIUM (BE) 2019-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194380-A1 METHOD FOR PRODUCING POLYESTER POLYOLS AND USE THEREOF IN POLYURETHANE PUF60, F12, C9 LMNA 740/4885KDM4E 1957/4885DUSP3 2134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.